
SUID was the largest single contributor to the Black-White infant mortality gap in 2024 and drove the biggest share of its rise since 2020.
Early diagnosis and treatment could drastically reduce the high medical, psychosocial, and economic costs of chlaymydial infections. So why are screening rates so low--especially in disproportionately affected younger women--and what can we do about it?






